Modulation of Spatial Memory Deficit and Hyperactivity in Dopamine Transporter Knockout Rats via α2A-Adrenoceptors

Modulation of Spatial Memory Deficit and Hyperactivity in Dopamine Transporter Knockout Rats via α2A-Adrenoceptors

Attention deficit hyperactivity disorder (ADHD) is manifested by a specific set of behavioral deficits such as hyperactivity, impulsivity, and inattention. The dopamine neurotransmitter system is postulated to be involved in the pathogenesis of ADHD. Guanfacine, a selective α2A-adrenoceptor agonist,...

Full description

Bibliographic Details
Main Authors:	Natalia Kurzina, Anastasia Belskaya, Arina Gromova, Alla Ignashchenkova, Raul R. Gainetdinov, Anna Volnova
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Series:	Frontiers in Psychiatry
Subjects:	dopamine transporter knockout (DAT-KO) rats ADHD model norepinephrine (NE) dopamine (DA) α2A-adrenoceptors Guanfacine (GF)
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2022.851296/full

Similar Items

Noradrenergic Modulation of Learned and Innate Behaviors in Dopamine Transporter Knockout Rats by Guanfacine
by: Anna Volnova, et al.
Published: (2023-01-01)

Effects of Atomoxetine on Motor and Cognitive Behaviors and Brain Electrophysiological Activity of Dopamine Transporter Knockout Rats
by: Maria Ptukha, et al.
Published: (2022-10-01)

A New Paradigm for Training Hyperactive Dopamine Transporter Knockout Rats: Influence of Novel Stimuli on Object Recognition
by: Natalia P. Kurzina, et al.
Published: (2021-04-01)

Alterations in Serotonin Neurotransmission in Hyperdopaminergic Rats Lacking the Dopamine Transporter
by: Dmitrii S. Traktirov, et al.
Published: (2023-10-01)

Alteration of Postural Reactions in Rats with Different Levels of Dopamine Depletion
by: Daria S. Kalinina, et al.
Published: (2023-07-01)

The effects of stress exposure on prefrontal cortex: Translating basic research into successful treatments for post-traumatic stress disorder
by: Amy F.T. Arnsten, et al.
Published: (2015-01-01)

Associative learning impairments in rats lacking dopamine transporter
by: A. A. Savchenko, et al.
Published: (2022-07-01)

Chronic Administrations of Guanfacine on Mesocortical Catecholaminergic and Thalamocortical Glutamatergic Transmissions
by: Kouji Fukuyama, et al.
Published: (2021-04-01)

Heterozygote Dopamine Transporter Knockout Rats Display Enhanced Cocaine Locomotion in Adolescent Females
by: Marta Pardo, et al.
Published: (2022-12-01)

Linking Ethanol-Addictive Behaviors With Brain Catecholamines: Release Pattern Matters
by: Vladimir P. Grinevich, et al.
Published: (2021-12-01)

Dopamine Transporter Deficient Rodents: Perspectives and Limitations for Neuroscience
by: Artem Savchenko, et al.
Published: (2023-05-01)

Practical clinical guidelines and pharmacological treatment for attention‐deficit hyperactivity disorder in Asia
by: Kentaro Kawabe, et al.
Published: (2024-03-01)

Early Adolescence Prefrontal Cortex Alterations in Female Rats Lacking Dopamine Transporter
by: Placido Illiano, et al.
Published: (2021-02-01)

Dopamine Transporter Knockout Rats Display Epigenetic Alterations in Response to Cocaine Exposure
by: Samara Vilca, et al.
Published: (2023-07-01)

Enhanced Dopamine Transmission and Hyperactivity in the Dopamine Transporter Heterozygous Mice Lacking the D3 Dopamine Receptor
by: Tatyana D. Sotnikova, et al.
Published: (2020-11-01)

Genetic Basis of Attention Deficit Hyperactivity Disorder
by: Nihal Yurteri, et al.
Published: (2011-01-01)

Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies
by: Wigal SB, et al.
Published: (2020-06-01)

Neurobiological correlation between attention-deficit/hyperactivity disorder and obesity
by: A.M. Romão Franco, et al.
Published: (2021-04-01)

Dopamine transporter knockout rats as the new preclinical model of hyper- and hypo-dopaminergic disorders
by: I. Sukhanov, et al.
Published: (2019-12-01)

Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA
by: Noelia Granado, et al.
Published: (2011-06-01)

Dopamine and norepinephrine role in alcohol-addictive behavior: from correlations to mechanisms
by: V. P. Grinevich, et al.
Published: (2022-10-01)

β3-ADRENOCEPTORS INHIBIT STIMULATED NOREPINEPHRINE RELEASE IN SPONTANEOUSLY HYPERTENSIVE RATS
by: Torill eBerg
Published: (2014-12-01)

Noradrenaline-induced release of newly-synthesized accumbal dopamine: differential role of alpha- and beta-adrenoceptors
by: Francisca eMeyer, et al.
Published: (2014-08-01)

Regulation of the genes involved in neurotransmission in Attention Deficit/Hyperactivity Disorder
by: Cuch Barbara, et al.
Published: (2015-06-01)

The Expression of Trace Amine-Associated Receptors (TAARs) in Breast Cancer Is Coincident with the Expression of Neuroactive Ligand–Receptor Systems and Depends on Tumor Intrinsic Subtype
by: Anastasia N. Vaganova, et al.
Published: (2023-09-01)

Are There Prevalent Sex Differences in Psychostimulant Use Disorder? A Focus on the Potential Therapeutic Efficacy of Atypical Dopamine Uptake Inhibitors
by: Melinda Hersey, et al.
Published: (2023-07-01)

Catecholaminergic and cholinergic neuromodulation in autism spectrum disorder: A comparison to attention-deficit hyperactivity disorder
by: Damian Koevoet, et al.
Published: (2023-01-01)

A retrospective medical chart review of clinical outcomes in children and adolescents with attention-deficit/hyperactivity disorder treated with guanfacine extended-release in routine Canadian clinical practice
by: Judy van Stralen, et al.
Published: (2021-10-01)

Dopamine-Depleted Dopamine Transporter Knockout (DDD) Mice: Dyskinesia with L-DOPA and Dopamine D1 Agonists
by: Vladimir M. Pogorelov, et al.
Published: (2023-11-01)

Knockout or Knock-in? A Truncated D2 Receptor Protein Is Expressed in the Brain of Functional D2 Receptor Knockout Mice
by: Natalia Sánchez, et al.
Published: (2021-06-01)

Neuropathology of the Brainstem to Mechanistically Understand and to Treat Alzheimer’s Disease
by: Ágoston Patthy, et al.
Published: (2021-04-01)

Genetic disruption of dopamine β-hydroxylase dysregulates innate responses to predator odor in mice
by: Joyce Liu, et al.
Published: (2024-03-01)

Guanfacine Normalizes the Overexpression of Presynaptic α-2A Adrenoceptor Signaling and Ameliorates Neuropathic Pain in a Chronic Animal Model of Type 1 Diabetes
by: Neha Munawar, et al.
Published: (2022-10-01)

Guanfacine treatment improves ADHD phenotypes of impulsivity and hyperactivity in a neurofibromatosis type 1 mouse model
by: J. L. Lukkes, et al.
Published: (2020-01-01)

Discovery of Trace Amine-Associated Receptor 1 (TAAR1) Agonist 2-(5-(4′-Chloro-[1,1′-biphenyl]-4-yl)-4<i>H</i>-1,2,4-triazol-3-yl)ethan-1-amine (LK00764) for the Treatment of Psychotic Disorders
by: Mikhail Krasavin, et al.
Published: (2022-11-01)

Using rodent data to elucidate dopaminergic mechanisms of ADHD: Implications for human personality
by: Gail Tripp, et al.
Published: (2024-01-01)

Successful management of suspected minoxidil toxicosis in a cat following accidental dermal exposure
by: Song JH, et al.
Published: (2022-06-01)

Dopamine-Serotonin Transporter Disease
by: J Gordon Millichap
Published: (2013-04-01)

Editorial: Neurotransmitters and Emotions
by: Fushun Wang, et al.
Published: (2020-01-01)

Zanthoxylum alatum abrogates lipopolysaccharide-induced depression-like behaviours in mice by modulating neuroinflammation and monoamine neurotransmitters in the hippocampus
by: Chandana Choudhury Barua, et al.
Published: (2018-01-01)